Risk Factors in Patients with Non-ST Segment Elevation Myocardial Infarction

Denis Mrsic1, Jasmina Smajlovic2, Daniela Loncar1

  • 1Clinic for Internal Medicine, University Clinical Center Tuzla.

Materia Socio-Medica
|January 11, 2021
PubMed

Insights

Smoking and hypertension are key risk factors for non-ST segment elevation myocardial infarction (NSTEMI). Identifying and managing these cardiovascular disease risks, especially in men and younger patients, is crucial for prevention.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Atherosclerotic epicardial coronary artery disease is the primary cause of myocardial ischemia, affecting 90% of patients.
  • Established risk factors are strongly linked to the development and progression of atherosclerotic disease.

Purpose of the Study:

  • To determine the prevalence of traditional coronary artery disease risk factors in patients diagnosed with non-ST segment elevation myocardial infarction (NSTEMI).
  • To analyze these risk factors in relation to patient gender.

Main Methods:

  • Retrospective analysis of 600 patients treated for NSTEMI.
  • Data collected from June 2016 to December 2019 at the Clinic for Internal Medicine, UKC Tuzla.

Main Results:

  • Smoking (65%) was the most prevalent risk factor, followed by hypertension (58%) and hyperlipoproteinemia (39%).
  • In males, smoking predominated (74%), while hypertension was most common in females (67%).
  • Younger patient groups showed smoking and family history as leading risks.

Conclusions:

  • Known risk factors for cardiovascular disease necessitate effective prevention and treatment strategies.
  • Smoking cessation significantly reduces reinfarction risk by 50%, highlighting its importance in secondary prevention.
  • Understanding and mitigating coronary risks enhances patient well-being and confidence.
Abstract

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
137
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
297
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
672
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
93
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
72
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
163